Menu Search
Equities

Aeon Co Ltd

8267:TYO

Aeon Co Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (JPY)4,016.00
  • Today's Change-3.00 / -0.07%
  • Shares traded2.28m
  • 1 Year change+30.60%
  • Beta0.4876
Data delayed at least 20 minutes, as of Sep 18 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy0
Outperform2
Hold5
Sell3
Strong Sell0

Share price forecast in JPY

The 8 analysts offering 12 month price targets for Aeon Co Ltd have a median target of 2,850.00, with a high estimate of 3,900.00 and a low estimate of 1,650.00. The median estimate represents a -29.03% decrease from the last price of 4,016.00.
High-2.9%3,900.00
Med-29.0%2,850.00
Low-58.9%1,650.00

Dividends in JPY

In 2024, Aeon Co Ltd reported a dividend of 36.00 JPY, equaling last years dividend. The 8 analysts covering the company expect dividends of 39.00 JPY for the upcoming fiscal year, an increase of 8.33%.
Div growth (TTM)0.00%
More ▼

Earnings history & estimates in JPY

On Jul 12, 2024, Aeon Co Ltd reported 1st quarter 2025 earnings of 5.99 per share.
The next earnings announcement is expected on Oct 09, 2024.
Average growth rate-74.53%
Aeon Co Ltd reported annual 2024 earnings of 52.25 per share on Apr 10, 2024.
Average growth rate+167.37%
More ▼

Revenue history & estimates in JPY

Aeon Co., Ltd. had 1st quarter 2025 revenues of 2.45bn. This missed the 2.47bn consensus estimate of the 2 analysts following the company. This was 5.35% above the prior year's 1st quarter results.
Average growth rate+1.44%
Aeon Co., Ltd. had revenues for the full year 2024 of 9.55bn. This was 4.79% above the prior year's results.
Average growth rate+2.67%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.